文献速递垂体与肾上腺疾病

垂体腺瘤影像学作为肢端肥大症诊断与结局的决定因素

Pituitary adenoma imaging as a determinant of acromegaly diagnosis and outcomes.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

本文综述垂体影像学在肢端肥大症诊治中的作用,指出生长激素腺瘤占病因>95%,大腺瘤仍占70%,但颅内影像普及使小腺瘤更早被发现。现有指南对最佳影像方案缺乏共识、扫描协议异质,作者基于文献综述提出标准化分层垂体影像方案并附在线决策工具。

要点

  • 生长激素腺瘤占肢端肥大症病因>95%,大腺瘤占70%。
  • 高质量影像决定手术与放疗的获益风险平衡。
  • 作者提出按患者特征分层的标准化垂体影像方案。

核心结论

  • 高质量影像可准确定位初发、残留或复发灶,是最大化垂体手术与放疗获益、降低正常腺体损伤风险的关键。

研究设计与样本

  • 基于对既往研究的综合综述,聚焦磁共振与分子(功能)成像技术近期进展,提出标准化分层垂体影像方案。

主要发现

  • 生长激素腺瘤占肢端肥大症病因>95%,大腺瘤在生长激素肿瘤中仍占70%。
  • 颅内影像更广泛使用使较小腺瘤被更早发现,给影像诊断带来新挑战。
  • 现有肢端肥大症管理指南对最佳影像缺乏共识,扫描协议仍异质,妨碍患者管理与中心间比较。

关键数值与推荐

  • 作者提出依据个体患者特征、并针对预期治疗方式制定的标准化分层垂体影像方案。
  • 提供可适配临床情境的在线工具以辅助决策。

临床怎么用

  • 在垂体肿瘤卓越中心外或重复手术时,垂体靶向手术与放疗对残留正常腺体有显著不良风险。
  • 应依据分层影像方案定位病灶,以指导手术或放疗决策并减少对正常腺体的损伤。

局限性

  • 原文未报告具体研究样本量、数值阈值或统计学比较结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In the majority (>95%) of patients with acromegaly, the underlying cause is a somatotroph adenoma. Pituitary-targeted surgery and radiotherapy can achieve long-term disease control but carry a significant adverse risk to the remaining normal gland, especially if undertaken outside a Pituitary Tumor Center of Excellence or when repeat surgery is performed. Maximizing benefits and minimizing the risks of pituitary surgery and radiotherapy is critically dependent on high-quality imaging that allows accurate localization of site(s) of either de novo, residual, or recurrent disease. Macroadenomas continue to predominate among somatotroph tumors (70%), but more widespread use of intracranial imaging leads to earlier detection of smaller adenomas, posing new challenges for imaging diagnostics. Despite several comprehensive guidelines on the management of acromegaly, there is little consensus regarding optimal imaging, and current scanning protocols remain heterogeneous. This serves as a barrier to optimal patient management and constrains comparison between centers, with inevitable consequences for research within the field. Here, based on a comprehensive review of previous studies and focusing on recent advances in magnetic resonance and molecular (functional) imaging techniques, we propose a standardized, tiered approach to pituitary imaging in patients with acromegaly, guided by individual patient features and tailored to the anticipated therapeutic approach. An online tool, which can be adapted to the clinical context, is provided as an aid to decision-making.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Haberbosch L, MacFarlane J, Gillett D, et al. Pituitary adenoma imaging as a determinant of acromegaly diagnosis and outcomes. J Clin Endocrinol Metab. 2026. PMID: 42029672. doi:10.1210/clinem/dgag179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。